Guide / US sourcing

How US medical imaging data sourcing feasibility works

A US medical imaging sourcing request should move through buyer specification, candidate-source assessment, aggregate feasibility, permission review, technical sampling and a programme decision. MedCorpora can assess and pursue US-sourced requirements, but does not present unverified sites, case counts, ground truth or permissions as ready inventory.

Published 30 July 2026 · Reviewed 12 August 2026 · MedCorpora
Step 1Buyer specification
Step 2Candidate-source assessment
Step 3Authority and technical checks
Step 4Qualified programme decision
01

What the programme covers

The phrase US-sourced can refer to care location, source organization, patient population or permitted processing and delivery. A sound feasibility process resolves those meanings and verifies the operational path rather than assuming that a country label proves availability.

02

What a useful specification includes

A defensible request defines the clinical task, source evidence and acceptance criteria before patient-level data moves. The exact fields and thresholds depend on the intended model claim.

  • US care setting, population and site requirements
  • Modality, anatomy, pathology and acquisition details
  • Case definitions and reference-standard evidence
  • Required reports, pathology, outcomes or annotations
  • Intended use, recipient, processing and delivery constraints
  • Target volume, timeline and validation design
03

Quality and validation controls

Each feasibility statement is assigned a status: verified inventory, inventory under verification, sourcing scope or buyer-specific feasibility. This prevents early source indications from being repeated as deliverable cohort claims.

  • Meaning of US-sourced documented
  • Candidate site and inventory status separated
  • Case-count logic and counting unit recorded
  • Ground truth and permission path checked
  • Unresolved assumptions and timeline dependencies listed
04

Availability, rights and delivery

If feasibility is positive, programme-specific authorization, privacy controls, technical acceptance and licence terms must still be completed before an approved release.

Public pages describe a sourcing and engineering capability, not guaranteed ready inventory. Each release remains subject to verified programme inventory, programme-specific authorization, privacy review, technical acceptance and buyer licence terms.

05

Questions, answered directly.

Does MedCorpora already hold every US imaging cohort?

No. US requirements are assessed and pursued through buyer-specific feasibility; availability is not assumed.

Can a US request include longitudinal outcomes?

It can be requested, but source coverage, linkage, permissions and follow-up must be verified.

What is the first information a buyer should provide?

Modality, pathology, cohort definitions, ground truth, geography, intended use, required components, approximate size and timeline.

When does patient-level data move?

Only after the appropriate programme authorization and technical controls are established.

Institutional engagement

Define the cohort.